Thermal proteome profiling of breast cancer cells reveals proteasomal activation by CDK4/6 inhibitor palbociclib

In conclusion, thermal proteome profiling identifies the proteasome and ECM29 protein as mediators of palbociclib activity in breast cancer cells.
Source: EMBO Journal - Category: Molecular Biology Authors: Tags: Cancer, Molecular Biology of Disease, Post-translational Modifications, Proteolysis & Proteomics Articles Source Type: research